CTS Corporation (CTS)
NYSEInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-05
NYSEInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-05
QuarterlyIQ Insights · CTS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -16.4% |
| Our one-year growth estimate | diamond | 8.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 25.3 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 30 industry peers · Company calendar date is not available
CTS — CEO transition
Dated 2026-06-25
President and CEO — Kieran O'Sullivan: Mr. O'Sullivan is stepping down as President and CEO but remains on the Board as Executive Chairman, while Pratik Trivedi has been appointed as new President and CEO.
Why it matters: CTS posted a 42.2% adjusted gross margin in Q3. A high margin would show that strong results continue.
Supportive ifCTS reports adjusted gross margin above 40% in Q4 2026.
Worry ifCTS reports adjusted gross margin at or below 40% in Q4 2026.
Why it matters: CTS raised its 2026 adjusted EPS range to $2.78–$2.88. Results above the low end would support its higher profit outlook.
Supportive ifCTS reports 2026 adjusted diluted EPS of at least $2.78.
Worry ifCTS reports 2026 adjusted diluted EPS below $2.78 or cuts its $2.78–$2.88 range.
Why it matters: These markets made up 60% of Q3 sales, and their growth is central to CTS’s plan to broaden its business.
Supportive ifIn a later quarter, sales across diverse markets rise from a year earlier. They remain at least 60% of total sales.
Worry ifSales across diverse markets fall from a year earlier or drop below 60% of total sales.
Why it matters: The sector notes say growth remains positive but is easing. A fall below its median would add to that slowdown signal.
Worry ifCTS reports revenue growth below its recent median in a later quarter, compared with the same quarter last year.
Less concerning ifCTS revenue growth stays at or above its recent median in a later quarter.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$113 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $358 loss on $10,000 · 3.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,228 loss on $10,000 · 22.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Millar adds medical sensing products to CTS. The stated revenue level gives a clear test of the deal’s progress.
Supportive ifCTS reports Millar near its stated $30 million annual revenue level by the second half of 2027.
Worry ifCTS reports Millar below that annual revenue level or delays the stated timing in the second half of 2027.
Why it matters: Transportation was flat over the last twelve months in the October slides. A new decline could offset growth in other markets.
Worry ifTransportation sales fall year over year in a later quarter.
Less concerning ifTransportation sales grow year over year in a later quarter.